139 related articles for article (PubMed ID: 26091306)
1. Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.
Yang Z; Zhang Y; Huang T; Feng H
Gut Microbes; 2015 Jul; 6(4):221-4. PubMed ID: 26091306
[TBL] [Abstract][Full Text] [Related]
2. Pyknotic cell death induced by Clostridium difficile TcdB: chromatin condensation and nuclear blister are induced independently of the glucosyltransferase activity.
Wohlan K; Goy S; Olling A; Srivaratharajan S; Tatge H; Genth H; Gerhard R
Cell Microbiol; 2014 Nov; 16(11):1678-92. PubMed ID: 24898616
[TBL] [Abstract][Full Text] [Related]
3. Comparison of wild type with recombinant Clostridium difficile toxin A.
Gerhard R; Burger S; Tatge H; Genth H; Just I; Hofmann F
Microb Pathog; 2005; 38(2-3):77-83. PubMed ID: 15748809
[TBL] [Abstract][Full Text] [Related]
4. A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.
Wang YK; Yan YX; Kim HB; Ju X; Zhao S; Zhang K; Tzipori S; Sun X
Hum Vaccin Immunother; 2015; 11(9):2215-22. PubMed ID: 26036797
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
Li S; Shi L; Yang Z; Feng H
Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
[TBL] [Abstract][Full Text] [Related]
6. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
Li S; Shi L; Yang Z; Zhang Y; Perez-Cordon G; Huang T; Ramsey J; Oezguen N; Savidge TC; Feng H
Infect Immun; 2015 Feb; 83(2):502-13. PubMed ID: 25404023
[TBL] [Abstract][Full Text] [Related]
7. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium.
Yang G; Zhou B; Wang J; He X; Sun X; Nie W; Tzipori S; Feng H
BMC Microbiol; 2008 Nov; 8():192. PubMed ID: 18990232
[TBL] [Abstract][Full Text] [Related]
8. A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity.
Zhang Y; Shi L; Li S; Yang Z; Standley C; Yang Z; ZhuGe R; Savidge T; Wang X; Feng H
PLoS One; 2013; 8(3):e58634. PubMed ID: 23484044
[TBL] [Abstract][Full Text] [Related]
9. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
10. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
11. The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis.
Bilverstone TW; Garland M; Cave RJ; Kelly ML; Tholen M; Bouley DM; Kaye P; Minton NP; Bogyo M; Kuehne SA; Melnyk RA
PLoS Pathog; 2020 Sep; 16(9):e1008852. PubMed ID: 32960931
[TBL] [Abstract][Full Text] [Related]
12. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
[TBL] [Abstract][Full Text] [Related]
13. Defective mutations within the translocation domain of Clostridium difficile toxin B impair disease pathogenesis.
Hamza T; Zhang Z; Melnyk RA; Feng H
Pathog Dis; 2016 Feb; 74(1):ftv098. PubMed ID: 26507679
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
[TBL] [Abstract][Full Text] [Related]
15. Repetitive domain of Clostridium difficile toxin B exhibits cytotoxic effects on human intestinal epithelial cells and decreases epithelial barrier function.
Zemljic M; Rupnik M; Scarpa M; Anderluh G; Palù G; Castagliuolo I
Anaerobe; 2010 Oct; 16(5):527-32. PubMed ID: 20620216
[TBL] [Abstract][Full Text] [Related]
16. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
[TBL] [Abstract][Full Text] [Related]
17. Glucosyltransferase-dependent and -independent effects of TcdB on the proteome of HEp-2 cells.
Erdmann J; Junemann J; Schröder A; Just I; Gerhard R; Pich A
Proteomics; 2017 Aug; 17(15-16):. PubMed ID: 28612519
[TBL] [Abstract][Full Text] [Related]
18. Glucosyltransferase Activity of Clostridium difficile Toxin B Triggers Autophagy-mediated Cell Growth Arrest.
He R; Peng J; Yuan P; Yang J; Wu X; Wang Y; Wei W
Sci Rep; 2017 Sep; 7(1):10532. PubMed ID: 28874882
[TBL] [Abstract][Full Text] [Related]
19. Functional defects in
Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
[No Abstract] [Full Text] [Related]
20. Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.
Zhang Y; Feng H
Pathog Dis; 2016 Jun; 74(4):ftw024. PubMed ID: 27044305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]